Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism.

[1]  W. Koch,et al.  β-Adrenergic Receptor-mediated DNA Synthesis in Cardiac Fibroblasts Is Dependent on Transactivation of the Epidermal Growth Factor Receptor and Subsequent Activation of Extracellular Signal-regulated Kinases* , 2002, The Journal of Biological Chemistry.

[2]  I. Mercier,et al.  β -Adrenergic Stimulation of Rat Cardiac Fibroblasts Promotes Protein Synthesis via the Activation of Phosphatidylinositol 3-kinase , 2001 .

[3]  L. Zhao,et al.  Release of pro- and anti-angiogenic factors by human cardiac fibroblasts: effects on DNA synthesis and protection under hypoxia in human endothelial cells. , 2001, Biochimica et biophysica acta.

[4]  S. Ball,et al.  The mechanism of angiotensin II-induced extracellular signal-regulated kinase-1/2 activation is independent of angiotensin AT(1A) receptor internalisation. , 2001, Cellular signalling.

[5]  E. Jackson,et al.  Endogenous Cyclic AMP-Adenosine Pathway Regulates Cardiac Fibroblast Growth , 2001, Hypertension.

[6]  U. Walter,et al.  Inhibition of rat cardiac fibroblast growth by cAMP – but not by cGMP-dependent protein kinase , 2001, Basic Research in Cardiology.

[7]  N. Fukuda,et al.  Role of Endogenous Angiotensin II in the Increased Expression of Growth Factors in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats , 2001, Journal of cardiovascular pharmacology.

[8]  J. Cleland,et al.  Clinical trials update: IMPROVEMENT‐HF, COPERNICUS, MUSTIC, ASPECT‐II, APRICOT and HEART , 2000, European journal of heart failure.

[9]  Å. Gustafsson,et al.  beta-adrenergic stimulation of rat cardiac fibroblasts enhances induction of nitric-oxide synthase by interleukin-1beta via message stabilization. , 2000, Molecular pharmacology.

[10]  G. Booz,et al.  Regulation of angiotensinogen gene expression and protein in neonatal rat cardiac fibroblasts by glucocorticoid and β-adrenergic stimulation , 2000, Basic Research in Cardiology.

[11]  H. Zimmer,et al.  Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture. , 2000, Cardiovascular research.

[12]  M. Bristow.  What Type of β-Blocker Should Be Used to Treat Chronic Heart Failure? , 2000 .

[13]  S. Harding,et al.  Functional evidence for a cyclic-AMP related mechanism of action of the beta(2)-adrenoceptor in human ventricular myocytes. , 2000, Journal of molecular and cellular cardiology.

[14]  M. Bristow.  β-Adrenergic Receptor Blockade in Chronic Heart Failure , 2000 .

[15]  D. Sawyer,et al.  Adrenergic regulation of myocardial apoptosis. , 2000, Cardiovascular research.

[16]  L. Brunton,et al.  Identification of G protein-coupled signaling pathways in cardiac fibroblasts: cross talk between G(q) and G(s). , 2000, American journal of physiology. Cell physiology.

[17]  M. Yacoub,et al.  INHIBITION OF HUMAN CARDIAC FIBROBLAST MITOGENESIS BY BLOCKADE OF MITOGEN‐ACTIVATED PROTEIN KINASE AND PHOSPHATIDYLINOSITOL 3‐KINASE , 1999, Clinical and experimental pharmacology & physiology.

[18]  J. Scheuer.  Catecholamines in cardiac hypertrophy. , 1999, The American journal of cardiology.

[19]  T. Yokoyama,et al.  Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. , 1999, American journal of physiology. Heart and circulatory physiology.

[20]  K. Kangawa,et al.  An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth. , 1999, Cardiovascular research.

[21]  B. Swynghedauw,et al.  Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.

[22]  C. Long,et al.  Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. , 1998, Cardiovascular research.

[23]  N. Kim,et al.  Regulation of myocardial extracellular matrix components by mechanical and chemical growth factors. , 1998, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[24]  E. Lakatta,et al.  Stimulation of P2Y receptors activates c-fos gene expression and inhibits DNA synthesis in cultured cardiac fibroblasts. , 1998, Cardiovascular research.

[25]  N. Takahashi,et al.  Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. , 1998, The Journal of clinical investigation.

[26]  K. Weber,et al.  Cultured myofibroblasts generate angiotensin peptides de novo. , 1997, Journal of molecular and cellular cardiology.

[27]  S. Fisher,et al.  Norepinephrine and ANG II stimulate secretion of TGF-beta by neonatal rat cardiac fibroblasts in vitro. , 1995, The American journal of physiology.

[28]  J. Pepper,et al.  Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle. , 1993, Circulation.

[29]  C. Long,et al.  Beta-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium. , 1993, Journal of molecular and cellular cardiology.

[30]  S. Ball,et al.  Characterization of the angiotensin II receptor expressed by the human hepatoma cell line, PLC-PRF-5. , 1992, European journal of pharmacology.

[31]  M. Eghbali,et al.  Effect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts after norepinephrine treatment. , 1991, The American journal of pathology.

[32]  O. Brodde.  Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. , 1991, Pharmacological reviews.

[33]  P. Korner,et al.  Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. , 1986, Circulation.

[34]  K. Swedberg,et al.  Comparison of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. , 1984, The American journal of cardiology.